Genetic background of type 2 diabetes

被引:2
作者
Wagner, Robert [1 ]
Staiger, Harald [1 ]
机构
[1] Univ Tubingen, Inst Diabet Forsch & Metab Erkrankungen, Helmholtz Zentrums Munchen, Otfried Muller Str 10, D-72076 Tubingen, Germany
来源
DIABETOLOGE | 2019年 / 15卷 / 03期
关键词
Diabetes mellitus; non-insulin dependent; Glucose metabolism disorders; Genetic loci; Inheritance patterns; Polymorphism; genetic; INSULIN-SECRETION; WEIGHT-LOSS; TCF7L2; VARIANTS; ASSOCIATION; CONCORDANCE; MELLITUS; OBESITY;
D O I
10.1007/s11428-019-0474-8
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Type 2 diabetes mellitus is amultifactorial disease with an obvious polygenetic component. Using family-based linkage analysis, candidate gene-based genotype-phenotype association analysis, and the by far most successful method of hypothesis-free genome-wide association analysis, a total of 403 independent, mostly common gene variants in 243 gene loci significantly associated with type 2 diabetes risk have been hitherto identified. The gene variant with the most robust effect on type 2 diabetes risk is located in the TCF7L2 (transcription factor 7-like 2) gene locus and reduces incretin sensitivity of pancreatic -cells and limits the therapeutic response to drugs that make use of the incretin axis. Such pathomechanistic insights are currently only available for very few of the type 2 diabetes genes. Pathomechanistic investigations are hampered by gene-gene, gene-lifestyle, and gene-environment interactions. This is one of the main reasons why the impact of the risk alleles on type 2 diabetes prediction is still very limited.
引用
收藏
页码:267 / 277
页数:11
相关论文
共 35 条
[31]   Peroxisome proliferator-activated receptor gamma (PPARG) modulates free fatty acid receptor 1 (FFAR1) dependent insulin secretion in humans [J].
Wagner, Robert ;
Hieronimus, Anja ;
Lamprinou, Apostolia ;
Heni, Martin ;
Hatziagelaki, Erifili ;
Ullrich, Susanne ;
Stefan, Norbert ;
Staiger, Harald ;
Haering, Hans-Ulrich ;
Fritsche, Andreas .
MOLECULAR METABOLISM, 2014, 3 (06) :676-680
[32]   Untangling the interplay of genetic and metabolic influences on beta-cell function: Examples of potential therapeutic implications involving TCF7L2 and FFAR1 [J].
Wagner, Robert ;
Staiger, Harald ;
Ullrich, Susanne ;
Stefan, Norbert ;
Fritsche, Andreas ;
Haering, Hans-Ulrich .
MOLECULAR METABOLISM, 2014, 3 (03) :261-267
[33]   Glucose-Raising Genetic Variants in MADD and ADCY5 Impair Conversion of Proinsulin to Insulin [J].
Wagner, Robert ;
Dudziak, Katarzyna ;
Herzberg-Schaefer, Silke A. ;
Machicao, Fausto ;
Stefan, Norbert ;
Staiger, Harald ;
Haering, Hans-Ulrich ;
Fritsche, Andreas .
PLOS ONE, 2011, 6 (08)
[34]   Pancreatic alpha cell-selective deletion of Tcf7l2 impairs glucagon secretion and counter-regulatory responses to hypoglycaemia in mice [J].
Xavier, Gabriela da Silva ;
Mondragon, Angeles ;
Mourougavelou, Vishnou ;
Cruciani-Guglielmacci, Celine ;
Denom, Jessica ;
Herrera, Pedro Luis ;
Magnan, Christophe ;
Rutter, Guy A. .
DIABETOLOGIA, 2017, 60 (06) :1043-1050
[35]   Influence of TCF7L2 gene variants on the therapeutic response to the dipeptidylpeptidase-4 inhibitor linagliptin [J].
Zimdahl, Heike ;
Ittrich, Carina ;
Graefe-Mody, Ulrike ;
Boehm, Bernhard O. ;
Mark, Michael ;
Woerle, Hans-Juergen ;
Dugi, Klaus A. .
DIABETOLOGIA, 2014, 57 (09) :1869-1875